Guardant Health (GH) Change in Cash (2017 - 2026)

Guardant Health has reported Change in Cash for 10 years, with the latest figure at $66.3 million in Q2 2026.

• Quarterly Change in Cash rose 196.97% year-over-year to $66.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $432.3 million (up 244.2% YoY) and the FY2025 annual result came in at -$140.3 million, up 72.15% from the prior year.
• Change in Cash fell to $66.3 million in Q2 2026 per GH's latest filing, from $612.0 million in the prior quarter.
• Over five years, Change in Cash peaked at $676.3 million in Q4 2023 and troughed at -$358.3 million in Q2 2022.
• A 5-year average of $37.5 million and a median of -$10.5 million in 2022 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2022 and 2023: Change in Cash slumped 616.41% in 2022, then soared 4158.59% in 2023.
• Over 5 years, Change in Cash stood at -$16.7 million in 2022, then jumped by 4158.59% to $676.3 million in 2023, then plunged by 108.67% to -$58.6 million in 2024, then sank by 241.39% to -$200.1 million in 2025, then jumped by 133.13% to $66.3 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered $66.3 million, $612.0 million, and -$200.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.